Literature DB >> 16985836

The use of botulinum toxin in men with benign prostatic hyperplasia.

Susan R Rusnack, Steven A Kaplan.   

Abstract

Entities:  

Year:  2005        PMID： 16985836      PMCID： PMC1477588     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  10 in total

1.  Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity.

Authors:  Hann-Chorng Kuo
Journal:  Urology       Date:  2003-03       Impact factor: 2.649

2.  Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.

Authors:  Hann-Chorng Kuo
Journal:  Urology       Date:  2005-04       Impact factor: 2.649

3.  Botulinum toxin A for spasticity, muscle spasms, and rigidity.

Authors:  M A Grazko; K B Polo; B Jabbari
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

4.  Autonomic innervation of the human prostate.

Authors:  A Vaalasti; A Hervonen
Journal:  Invest Urol       Date:  1980-01

Review 5.  Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.

Authors:  Francisco Cruz; Carlos Silva
Journal:  Curr Opin Urol       Date:  2004-11       Impact factor: 2.309

6.  Botox-induced prostatic involution.

Authors:  R Doggweiler; D H Zermann; M Ishigooka; R A Schmidt
Journal:  Prostate       Date:  1998-09-15       Impact factor: 4.104

7.  Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia.

Authors:  A T Cockett; P A di Sant'Agnese; P Gopinath; S R Schoen; P A Abrahamsson
Journal:  Urology       Date:  1993-11       Impact factor: 2.649

Review 8.  Prostatic tissue ablation by injection: a literature review.

Authors:  Mark K Plante; Jeffrey B Folsom; Peter Zvara
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

9.  Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.

Authors:  Giorgio Maria; Giuseppe Brisinda; Ignazio Massimo Civello; Anna Rita Bentivoglio; Gabriele Sganga; Alberto Albanese
Journal:  Urology       Date:  2003-08       Impact factor: 2.649

10.  Human prostate muscarinic receptor subtypes.

Authors:  M R Ruggieri; M D Colton; P Wang; J Wang; R J Smyth; M A Pontari; G R Luthin
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030
  10 in total
  2 in total

Review 1.  Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2016-04-21       Impact factor: 4.546

Review 2.  Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders.

Authors:  Yu-Hua Lin; Bing-Juin Chiang; Chun-Hou Liao
Journal:  Toxins (Basel)       Date:  2020-02-18       Impact factor: 4.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.